Enter the first few characters of Company and click 'Go'
| Deal Date | Buy/Sell | Client Name | Quantity | Price (Rs.) |
| Jan 25, 2024 | B | MARSHALL WACE INVESTMENT STRATEGIESGTOPS FUND | 6,559 | 4,999.60 |
| Jan 25, 2024 | B | MARSHALLWACEINVESTMENTSTRATEGIESMARKETNEUTRALTOPSFUND | 65,337 | 4,999.60 |
| Jan 25, 2024 | B | MARSHALL WACE INVESTMENT STRATEGIES - EUREKA FUND | 70,355 | 4,999.60 |
| Jan 25, 2024 | B | SOCIETE GENERALE | 3,08,994 | 4,999.60 |
| Jan 25, 2024 | S | BNP PARIBAS ARBITRAGE | 1,42,251 | 4,999.60 |
| Jan 25, 2024 | S | BNP PARIBAS ARBITRAGE | 3,08,994 | 4,999.60 |
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
More Information on Alkem Laboratories Ltd.
-
Alkem Laboratories Ltd. Tools
- Bulk Deals
- Block Deals
-
Alkem Laboratories Ltd. Company Details
- Company Profile
- Company History
- Management Team
- Capital Structure
- Product Mix
- Banker/Auditor/Registrar
-
Company History
- BSE Price History
- NSE Price History
-
Alkem Laboratories Ltd. Key Financial Ratios
- Ratios
-
Alkem Laboratories Ltd. Results
- Quarterly Results
- Half Yearly Results
- Nine Months Results
- Annual Results
-
Alkem Laboratories Ltd. Financial Data
- Audited Results
- Cash Flow
- Balance Sheet
-
Alkem Laboratories Ltd. Reports
- Accounting Policies
- Auditors Report
- Directors Report
- Notes To Account
-
Alkem Laboratories Ltd. Corporate Announcements
- Book Closure
- Dividend
- Board Meetings
Enable